Voriconazole Powder, For Suspension
Product Images NDC 43386-038

6 FDA label images from Lupin Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 43386-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (9b8865b7 Cdc3 4505 B9ba B3ab1bf909d6 01)

Structure (9b8865b7 Cdc3 4505 B9ba B3ab1bf909d6 01)
Chemical structure of voriconazole, the active ingredient in VORICONAZOLE oral powder for suspension, showing its molecular arrangement with key functional groups including fluorine atoms and an alcohol group.*
FDA Label Image

Image (1ce2b72f Bdcc 4c19 979a 269d1098215b 397 1)

Image (1ce2b72f Bdcc 4c19 979a 269d1098215b 397 1)
VORICONAZOLE oral powder for suspension, 40 mg/mL, in a carton package. The label indicates the medication's proprietary and generic names along with the strength and dosage form. It is manufactured by Lupin Pharmaceuticals, Inc. The carton includes usage instructions and regulatory information relevant to the human prescription drug.*
FDA Label Image

Instructions (9b8865b7 Cdc3 4505 B9ba B3ab1bf909d6 02)

Instructions (9b8865b7 Cdc3 4505 B9ba B3ab1bf909d6 02)
Assembly instructions for voriconazole oral suspension powder, for use after reconstitution. Step-by-step illustrations show how to open the bottle cap, insert the bottle adapter fully, attach the oral dispenser, draw the prescribed dose by pulling the plunger, dispensing the medicine into the mouth, and then replacing the cap with the adapter in place. Users are reminded to shake the bottle before use, store at room temperature, and rinse the oral dispenser after each dose.*
FDA Label Image

Image (1ce2b72f Bdcc 4c19 979a 269d1098215b 34 1)

Image (1ce2b72f Bdcc 4c19 979a 269d1098215b 34 1)
VORICONAZOLE oral powder for suspension 40 mg/mL carton from Lupin Pharmaceuticals, Inc. The packaging is predominantly white with a large stylized black and gray geometric design resembling a flower or snowflake. The product name and strength are not distinctly visible on the image.*
FDA Label Image

50 mg (30 count)

50 mg (30 count)
Label for VORICONAZOLE oral suspension powder, 40 mg/mL strength, orange-flavored, supplied by Lupin Pharmaceuticals, Inc. The label includes reconstitution instructions, storage conditions, and notes that the dry powder weighs 49 g yielding 75 mL suspension when reconstituted. Manufacturer information and an NDC number 43386-038-60 are also visible.*
FDA Label Image

200 mg (500 count)

200 mg (500 count)
Packaging label for Voriconazole for Oral Suspension, 40 mg/mL, orange-flavored powder for suspension. The label shows the product's NDC 43386-038-60, manufactured for Lupin Pharmaceuticals, Inc. It includes administration instructions, precautions, and a barcode. The net weight is 49 g (75 mL when reconstituted), with an oral dispenser included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.